Global Vascular Access Devices Market Assessment, By Product Type [Central Vascular Access Device, Peripheral Vascular Access Device, Accessories], By Application [Drug Administration, Fluid and Nutrition Administration, Blood Transfusion, Diagnostics], By End-user [Hospitals, Clinics, Ambulatory Surgical Centers, Others], By Region, Opportunities and Forecast, 2017-2031F

Global vascular access devices market is projected to witness a CAGR of 5.83% during the forecast period 2024-2031, growing from USD 3.63 billion in 2023 to USD 5.71 billion in 2031. With increasing disease burden, rising hospitalization, and an improved healthcare system, the market of vascular access devices is anticipated to expand at a notable pace during the forecast period.

Vascular access devices are insertions used to administer drugs, fluids, blood, and nutrients in blood vessels. These devices include peripherally inserted central catheters (PICCs), central venous catheters, implantable ports, and peripheral intravenous catheters (PIVCs). With the never-ending evolution of healthcare services and medical devices, vascular access devices have evolved in terms of design, material, and integration of imaging technologies in it. Advancements in vascular access devices have improved biocompatibility, flexibility, and the adoption of novel materials, enhancing patient outcomes and quality of life. The rising demand for vascular access devices is driven by the growing burden of lifestyle diseases, technological advancements, and the need for minimally invasive procedures. Manufacturers are consistently working to enhance device design and materials to improve patient outcomes and reduce complications.

For instance, in May 2024, Teleflex Incorporated launched the Arrow EZ-IO Intraosseous Access Procedure Tray, enhancing its intraosseous vascular access portfolio. It includes all necessary components for intraosseous access, featuring the first FDA-cleared battery-powered driver that can be utilized in sterile environments. The tray is designed for quick and precise insertion, addressing the challenges clinicians face in obtaining vascular access during emergencies. However, risks associated with long-term use of catheters, such as infections and sepsis may pose challenges for market growth.

Rising Burden of Chronic Diseases to Increase the Market Size

The chronic disease burden is on a rise globally, owing to the increasing prevalence of chronic diseases, such as cancer, cardiovascular and urological disorders, and others, which necessitates frequent and long-term vascular access for treatments such as chemotherapy, dialysis, and medication administration, thereby driving the demand for various types of vascular access devices, including central venous catheters and peripheral IV catheters. Another factor contributing to the growing burden is the rising geriatric population, highly prone to catching such diseases. With the ongoing scenario, the future demand for vascular access devices is anticipated to increase further.

For instance, the National Institute of Health (NIH), anticipates that the number of adults 50 years and older suffer from at least one chronic disease, which will increase by 99.5% from 71.522 million in 2020 to 142.66 million in 2050. An estimated 48 million people, or 47% of all deaths globally, are expected to die from severe health-related suffering by 2060, an 87% increase from 26 million in 2016. It is anticipated that 83% of these deaths will occur in low and middle-income countries. As per World Health Organization (WHO) estimates, by 2050, there will be twice as many people 60 years or older on the planet with the population of 2.1 billion.

Design Improvements to Drive Market Demand

The established types of vascular access devices include central venous catheters (CVCs), arteriovenous fistulas (AVFs), and arteriovenous grafts (AVGs). Innovations in CVC tip and coating design have improved patency and blood flow rates. AVFs are preferred over CVCs as they are less prone to clotting and infection while providing reliable and adequate blood flow rates. With such design enhancements, the AVF creation devices have significant traction leading to market growth. Market players are taking chances to launch innovative products with enhanced designs. For instance, in September 2023, Laminate Medical Technologies announced that it received US-FDA clearance for its VasQ External Vascular Support device, designed to create AVFs for dialysis access. Notably, 80% of patients in trials using VasQ were able to remove central venous catheters within their first year of treatment, reducing the risk of infection compared to traditional AVFs. The VasQ device provides structural reinforcement to the vessels during AVF creation, promoting better arterial flow and functionality.

Drug Administration Application to Dominate Vascular Access Devices Market Share

The drug administration application of the vascular access devices market is anticipated to cover the highest market share. As these devices provide reliable, long-term access to the bloodstream, which is essential for patients needing frequent or prolonged intravenous therapies, such as chemotherapy or chronic disease management, reducing complications associated with traditional IV lines, such as infections and vein irritation, by minimizing the need for repeated needle sticks. A recent study published in the British Medical Journal in July 2024 examined the effectiveness of vascular access devices (VADs) in reducing infection rates among hospitalized patients. The study concluded that VADs along with specific safety measures reduce the chances of infection.

Download Free Sample Report

North America Dominates the Global Vascular Access Devices Market Share

North America is anticipated to hold major market share of the global vascular access devices market. North America's leadership in the demand for vascular access devices is attributed to its advanced healthcare infrastructure, rising prevalence of chronic diseases, technological innovations, supportive regulations, and demographic trends favoring increased healthcare needs. According to the United States Renal Data System 2023 Annual Data Report, published in April 2024, more than 85% of individuals who began hemodialysis used a catheter. Additionally, nearly three-quarters of the United States population started without permanent access, a significant increase from about 65% in 2018. This rise in number clearly shows an increasing consumption of such devices in North America causing it to hold the largest market share among other regions.

Future Market Scenario (2024 – 2031F)

The vascular access devices market has witnessed several remarkable futuristic advancements that are anticipated to shape the future of such devices. These advancements include wearable technology, remote monitoring of atrioventricular flow, use of biocompatible materials for product design, 3D printing technology, image-guided vascular access devices, and others. The USFDA approval of WavelinQ and Ellipsys, two vascular access devices that facilitate the creation of arteriovenous fistulas (AVFs) using minimally invasive techniques has paved a new path for more products in line with endovascular fistula creation. The of the most revolutionary advancement is the image-guided vascular access system, Ultreon 1.0 launched by Abbott in October 2023. This platform uses near-infrared light to provide high-definition, precise imaging from within the blood vessels, allowing the healthcare professional precise access to blood vessels even in the most complex anatomies.

Report Scope

“Vascular Access Devices Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of global vascular access devices market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.

Report Attribute	Details
Base Year of the Analysis	2023
Historical Period	2017-2022
Forecast Period	2024-2031
Projected Growth Rate	CAGR of 5.83% between 2024 and 2031
Revenue Forecast in 2031	USD 5.71 billion
Segments Covered	Product Type, Application, End-user
Regions Covered	North America, Europe, South America, Asia-Pacific, Middle East and Africa
Key Companies Profile	Becton Dickinson and Company, Teleflex Incorporated, B. Braun Holding GmbH & Co. KG, AngioDynamics, Inc., Smiths Medical, Inc., Medtronic plc, Cook Medical Inc., Terumo Medical Corporation, Nipro Medical Corporation, Access Vascular, Inc.
Customization Scope	15% free report customization with purchase
Pricing and Purchase Options	Avail the customized purchase options to fulfill your precise research needs
Delivery Format	PDF and Excel through email (subject to the license purchased)

In the report, global vascular access devices market has been segmented into the following categories: 

• By Product Type
  • Central Vascular Access Device
    • Peripherally Inserted Central Catheters
    • Tunneled Catheters
    • Non-Tunneled Catheters
    • Implanted Ports
  • Peripheral Vascular Access Device
    • Peripheral Short Devices
    • Peripheral Midline Devices
    • Butterfly/Winged Steel Needles
  • Accessories
• By Application
  • Drug Administration
  • Fluid and Nutrition Administration
  • Blood Transfusion
  • Diagnostics
• By End-user
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others
• By Region
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Key Players Landscape and Outlook

The market witnessed some substantial market deals such as acquisitions, regulatory approvals, and product launches to expand the share of key players in the global vascular access devices market. In June 2023, Merit Medical announced two strategic acquisitions totaling USD 132.5 million to enhance its dialysis catheter portfolio. Merit Medical is acquiring dialysis catheters and a sealant system from AngioDynamics for USD 100 million, which complements its biopsy devices by preventing pneumothorax during lung biopsies. Additionally, Merit is purchasing the Surfacer catheter system from Bluegrass Vascular Technologies for USD 32.5 million, which facilitates central venous access.

In November 2023, BD launched the SiteRite 9 Ultrasound System, which is an advanced vascular access ultrasound designed to enhance clinician efficiency in placing peripherally inserted central catheters (PICCs), central venous catheters, and IV lines. SiteRite 9 aims to increase first-attempt insertion success and reduce unnecessary needlesticks, supporting BD's vision of a One-Stick Hospital Stay. The system received 510(k) Clearances in September 2023 and is available in the United States market.

Key Players Operating in Global Vascular Access Devices Market are:

• Becton Dickinson and Company
• Teleflex Incorporated
• Braun Holding GmbH & Co. KG
• AngioDynamics, Inc.
• Smiths Medical, Inc.
• Medtronic plc
• Cook Medical Inc.
• Terumo Medical Corporation
• Nipro Medical Corporation
• Access Vascular, Inc.

Markets and Data report answers the following questions:

• What is the current and future market size of the product/service in question globally or specific to different countries?
• How are the markets divided into different product/service segments and the market size and growth of each segment?
• What is the market potential of different product segments and their investment case?
• How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
• What is the business environment and regulatory landscape specific to the product/service?

If you can't find what you're searching for or have any custom requirements for global vascular access devices market, you may approach our team at info@marketsandata.com.